Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Clinical trial NCT00311857 · UNKNOWN

Trial details

NCT number: NCT00311857
Sponsor: Heidelberg University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2006-02-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.